Detection of HCV antigens in liver graft: Relevance to the management of recurrent post-liver transplant hepatitis C

Alberto Grassi, Chiara Quarneti, Matteo Ravaioli, Francesco Bianchini, Micaela Susca, Antonia D'Enrrico, Fabio Piscaglia, Maria Rosa Tamè, Pietro Andreone, GianLuca Grazi, Silvia Galli, Daniela Zaull, Antonio D. Pinna, Francesco B. Bianchi, Giorgio Ballardini

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

The aim of this study was to evaluate how the immunohistochemical detection of liver hepatitis C virus (HCV) antigens (HCV-Ag) could support the histologic diagnosis and influence the clinical management of post-liver transplantation (LT) liver disease. A total of 215 liver specimens from 152 HCV-positive patients with post-LT liver disease were studied. Histologic coding was: hepatitis (126), rejection (34), undefined (24; coexisting rejection grade I and hepatitis), or other (31). The percentage of HCV-Ag infected hepatocytes were evaluated, on frozen sections, by an immunoperoxidase technique. HCV-Ag were detectable early in 57% of cases within 30 days post-LT, 92% of cases between 31 and 180 days, and 74% of cases after more than 180 days. Overall, HCV-Ag were detected more frequently in histologic hepatitis as compared to rejection (P <0.0001) with a higher percentage of positive hepatocytes (P <0.00001). In 16 patients with a high number of HCV-Ag-positive hepatocytes (65%; range 40-90%) a clinical diagnosis of recurrent hepatitis (RHC) was made despite inconclusive histopathologic diagnosis. Multivariate analysis identified the percentage of HCV-Ag-positive hepatocytes and the time post-LT as independent predictors for RHC (P = 0.008 and P = 0.041, respectively) and the number of HCV-Ag-positive hepatocytes ≥50% as the only independent predictor for nonresponse (P <0.001) in 26 patients treated with α-interferon plus ribavirin. In conclusion, HCV reinfection occurs early post-LT, reaching its peak within 6 months. Immunohistochemical detection of post-LT HCV reinfection support the diagnosis of hepatitis when the histologic features are not conclusive. A high number of infected cells, independently from the genotype, represents a negative predictive factor of response to antiviral treatment.

Original languageEnglish
Pages (from-to)1673-1681
Number of pages9
JournalLiver Transplantation
Volume12
Issue number11
DOIs
Publication statusPublished - Nov 2006

Fingerprint

Hepatitis C Antigens
Hepatitis C
Hepacivirus
Transplants
Liver Transplantation
Liver
Hepatitis
Hepatocytes
Liver Diseases
Ribavirin
Frozen Sections
Immunoenzyme Techniques
Interferons
Antiviral Agents

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Grassi, A., Quarneti, C., Ravaioli, M., Bianchini, F., Susca, M., D'Enrrico, A., ... Ballardini, G. (2006). Detection of HCV antigens in liver graft: Relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transplantation, 12(11), 1673-1681. https://doi.org/10.1002/lt.20882

Detection of HCV antigens in liver graft : Relevance to the management of recurrent post-liver transplant hepatitis C. / Grassi, Alberto; Quarneti, Chiara; Ravaioli, Matteo; Bianchini, Francesco; Susca, Micaela; D'Enrrico, Antonia; Piscaglia, Fabio; Tamè, Maria Rosa; Andreone, Pietro; Grazi, GianLuca; Galli, Silvia; Zaull, Daniela; Pinna, Antonio D.; Bianchi, Francesco B.; Ballardini, Giorgio.

In: Liver Transplantation, Vol. 12, No. 11, 11.2006, p. 1673-1681.

Research output: Contribution to journalArticle

Grassi, A, Quarneti, C, Ravaioli, M, Bianchini, F, Susca, M, D'Enrrico, A, Piscaglia, F, Tamè, MR, Andreone, P, Grazi, G, Galli, S, Zaull, D, Pinna, AD, Bianchi, FB & Ballardini, G 2006, 'Detection of HCV antigens in liver graft: Relevance to the management of recurrent post-liver transplant hepatitis C', Liver Transplantation, vol. 12, no. 11, pp. 1673-1681. https://doi.org/10.1002/lt.20882
Grassi, Alberto ; Quarneti, Chiara ; Ravaioli, Matteo ; Bianchini, Francesco ; Susca, Micaela ; D'Enrrico, Antonia ; Piscaglia, Fabio ; Tamè, Maria Rosa ; Andreone, Pietro ; Grazi, GianLuca ; Galli, Silvia ; Zaull, Daniela ; Pinna, Antonio D. ; Bianchi, Francesco B. ; Ballardini, Giorgio. / Detection of HCV antigens in liver graft : Relevance to the management of recurrent post-liver transplant hepatitis C. In: Liver Transplantation. 2006 ; Vol. 12, No. 11. pp. 1673-1681.
@article{02d3ed35a457449089dee96d9682ffd4,
title = "Detection of HCV antigens in liver graft: Relevance to the management of recurrent post-liver transplant hepatitis C",
abstract = "The aim of this study was to evaluate how the immunohistochemical detection of liver hepatitis C virus (HCV) antigens (HCV-Ag) could support the histologic diagnosis and influence the clinical management of post-liver transplantation (LT) liver disease. A total of 215 liver specimens from 152 HCV-positive patients with post-LT liver disease were studied. Histologic coding was: hepatitis (126), rejection (34), undefined (24; coexisting rejection grade I and hepatitis), or other (31). The percentage of HCV-Ag infected hepatocytes were evaluated, on frozen sections, by an immunoperoxidase technique. HCV-Ag were detectable early in 57{\%} of cases within 30 days post-LT, 92{\%} of cases between 31 and 180 days, and 74{\%} of cases after more than 180 days. Overall, HCV-Ag were detected more frequently in histologic hepatitis as compared to rejection (P <0.0001) with a higher percentage of positive hepatocytes (P <0.00001). In 16 patients with a high number of HCV-Ag-positive hepatocytes (65{\%}; range 40-90{\%}) a clinical diagnosis of recurrent hepatitis (RHC) was made despite inconclusive histopathologic diagnosis. Multivariate analysis identified the percentage of HCV-Ag-positive hepatocytes and the time post-LT as independent predictors for RHC (P = 0.008 and P = 0.041, respectively) and the number of HCV-Ag-positive hepatocytes ≥50{\%} as the only independent predictor for nonresponse (P <0.001) in 26 patients treated with α-interferon plus ribavirin. In conclusion, HCV reinfection occurs early post-LT, reaching its peak within 6 months. Immunohistochemical detection of post-LT HCV reinfection support the diagnosis of hepatitis when the histologic features are not conclusive. A high number of infected cells, independently from the genotype, represents a negative predictive factor of response to antiviral treatment.",
author = "Alberto Grassi and Chiara Quarneti and Matteo Ravaioli and Francesco Bianchini and Micaela Susca and Antonia D'Enrrico and Fabio Piscaglia and Tam{\`e}, {Maria Rosa} and Pietro Andreone and GianLuca Grazi and Silvia Galli and Daniela Zaull and Pinna, {Antonio D.} and Bianchi, {Francesco B.} and Giorgio Ballardini",
year = "2006",
month = "11",
doi = "10.1002/lt.20882",
language = "English",
volume = "12",
pages = "1673--1681",
journal = "Liver Transplantation",
issn = "1527-6465",
publisher = "John Wiley and Sons Ltd",
number = "11",

}

TY - JOUR

T1 - Detection of HCV antigens in liver graft

T2 - Relevance to the management of recurrent post-liver transplant hepatitis C

AU - Grassi, Alberto

AU - Quarneti, Chiara

AU - Ravaioli, Matteo

AU - Bianchini, Francesco

AU - Susca, Micaela

AU - D'Enrrico, Antonia

AU - Piscaglia, Fabio

AU - Tamè, Maria Rosa

AU - Andreone, Pietro

AU - Grazi, GianLuca

AU - Galli, Silvia

AU - Zaull, Daniela

AU - Pinna, Antonio D.

AU - Bianchi, Francesco B.

AU - Ballardini, Giorgio

PY - 2006/11

Y1 - 2006/11

N2 - The aim of this study was to evaluate how the immunohistochemical detection of liver hepatitis C virus (HCV) antigens (HCV-Ag) could support the histologic diagnosis and influence the clinical management of post-liver transplantation (LT) liver disease. A total of 215 liver specimens from 152 HCV-positive patients with post-LT liver disease were studied. Histologic coding was: hepatitis (126), rejection (34), undefined (24; coexisting rejection grade I and hepatitis), or other (31). The percentage of HCV-Ag infected hepatocytes were evaluated, on frozen sections, by an immunoperoxidase technique. HCV-Ag were detectable early in 57% of cases within 30 days post-LT, 92% of cases between 31 and 180 days, and 74% of cases after more than 180 days. Overall, HCV-Ag were detected more frequently in histologic hepatitis as compared to rejection (P <0.0001) with a higher percentage of positive hepatocytes (P <0.00001). In 16 patients with a high number of HCV-Ag-positive hepatocytes (65%; range 40-90%) a clinical diagnosis of recurrent hepatitis (RHC) was made despite inconclusive histopathologic diagnosis. Multivariate analysis identified the percentage of HCV-Ag-positive hepatocytes and the time post-LT as independent predictors for RHC (P = 0.008 and P = 0.041, respectively) and the number of HCV-Ag-positive hepatocytes ≥50% as the only independent predictor for nonresponse (P <0.001) in 26 patients treated with α-interferon plus ribavirin. In conclusion, HCV reinfection occurs early post-LT, reaching its peak within 6 months. Immunohistochemical detection of post-LT HCV reinfection support the diagnosis of hepatitis when the histologic features are not conclusive. A high number of infected cells, independently from the genotype, represents a negative predictive factor of response to antiviral treatment.

AB - The aim of this study was to evaluate how the immunohistochemical detection of liver hepatitis C virus (HCV) antigens (HCV-Ag) could support the histologic diagnosis and influence the clinical management of post-liver transplantation (LT) liver disease. A total of 215 liver specimens from 152 HCV-positive patients with post-LT liver disease were studied. Histologic coding was: hepatitis (126), rejection (34), undefined (24; coexisting rejection grade I and hepatitis), or other (31). The percentage of HCV-Ag infected hepatocytes were evaluated, on frozen sections, by an immunoperoxidase technique. HCV-Ag were detectable early in 57% of cases within 30 days post-LT, 92% of cases between 31 and 180 days, and 74% of cases after more than 180 days. Overall, HCV-Ag were detected more frequently in histologic hepatitis as compared to rejection (P <0.0001) with a higher percentage of positive hepatocytes (P <0.00001). In 16 patients with a high number of HCV-Ag-positive hepatocytes (65%; range 40-90%) a clinical diagnosis of recurrent hepatitis (RHC) was made despite inconclusive histopathologic diagnosis. Multivariate analysis identified the percentage of HCV-Ag-positive hepatocytes and the time post-LT as independent predictors for RHC (P = 0.008 and P = 0.041, respectively) and the number of HCV-Ag-positive hepatocytes ≥50% as the only independent predictor for nonresponse (P <0.001) in 26 patients treated with α-interferon plus ribavirin. In conclusion, HCV reinfection occurs early post-LT, reaching its peak within 6 months. Immunohistochemical detection of post-LT HCV reinfection support the diagnosis of hepatitis when the histologic features are not conclusive. A high number of infected cells, independently from the genotype, represents a negative predictive factor of response to antiviral treatment.

UR - http://www.scopus.com/inward/record.url?scp=33751009648&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751009648&partnerID=8YFLogxK

U2 - 10.1002/lt.20882

DO - 10.1002/lt.20882

M3 - Article

C2 - 17031825

AN - SCOPUS:33751009648

VL - 12

SP - 1673

EP - 1681

JO - Liver Transplantation

JF - Liver Transplantation

SN - 1527-6465

IS - 11

ER -